Long-term survival after bronchial sleeve resection: Univariate and multivariate analyses

Schil, Paul E. Van; Rivière, Aart Brutel de la; Knaepen, Paul J.; Swieten, Henri A. van; Reher, Stefan W.; Goossens, D.; Vanderschueren, R. G. J. R. A.; Bosch, J.L.H. Ruud

doi:10.1016/0003-4975(96)00006-9

Cited by 63 publications

(40 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Within the postoperative period, 12 (8.1%) patients had grade 3 or greater complications, which is comparable to the rate in the current literature [20][21][22][23][24]. In addition, we examined the DFS and OS of our patient cohort and found a 5-year OS of 54.2%, which is comparable to that of studies that used a thoracotomy approach, which ranged from 46 to 56% [20][21][22][23][24][25]. We can make only a limited comparison of our DFS outcome of 36.7% at 5 years with that in the current literature because there is only one study reporting on DFS data [25].…”

Section: Discussionsupporting

confidence: 87%

Long-term outcome of hybrid surgical approach of video-assisted minithoracotomy sleeve lobectomy for non-small-cell lung cancer

Shao

Cao

et al. 2011

Surg Endosc

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 87%

Long-term outcome of hybrid surgical approach of video-assisted minithoracotomy sleeve lobectomy for non-small-cell lung cancer

Shao

Cao

et al. 2011

Surg Endosc

View full text Add to dashboard Cite

show abstract

“…In a collective review of 1,915 patients submitted to bronchoplastic procedures over a 12-yr period (1980)(1981)(1982)(1983)(1984)(1985)(1986)(1987)(1988)(1989)(1990)(1991)(1992), TEDDER et al [72] reported a 30-day operative mortality of 5.5% (range 0-11%) and 5-yr survival of 40%. Other authors have reported similar favourable outcomes [73,74].…”

Section: T3: Proximal Airway Tumourssupporting

confidence: 59%

Current surgical treatment of nonsmall cell lung cancer 2001

Deslauriers¹

2002

European Respiratory Journal

View full text Add to dashboard Cite

Recognizing that surgical treatment is still the best option for controlling lung cancer, surgeons want an operation to be performed when the benefits clearly outweigh the possible risks, and when it has been determined that cancer resection is the most appropriate course of management. The necessity for a compulsive attitude toward preoperative assessment is therefore to be emphasized.Approximately 45% of all lung cancers are limited to the chest, where surgical resection is the most effective method of controlling the disease. Patients with tumour (T) 1, node (N) 0 and T2N0 tumours have early lung cancer, and most are curable by resection, with 5-yr survival rates in the range 75-80% for patients with T1N0 status. The "gold standard" of surgery remains lobectomy. Stage T1N1 and T2N1 carcinomas represent a group of patients in whom the disease involves hilar and bronchopulmonary nodes. This group is best treated by complete resection and mediastinal lymphadenectomy.Survival data following surgical resection of T3 tumours clearly show better survival in patients with T3N0 disease than in those with T3N1-2 disease. Five-year survival rates for completely resected T3N0 lesions are in the range 30-50%. Once N1 disease is present, survival decreases to 15-20%. Incomplete resections fail to cure and surgery is not indicated if N2 disease is documented preoperatively. On occasion, T4 tumours involving the carina or vertebral body can be completely resected but T4N1-2 lesions are virtually incurable by surgery.The presence of mediastinal lymph node metastasis (N2/N3 disease) is an ominous prognostic sign and stage III-b disease, by virtue of metastatic contralateral nodes, is an absolute contraindication to surgical resection. Induction treatments with chemoradiation have shown prolongation of survival and three randomized trials have demonstrated a survival advantage over surgery alone.

show abstract

“…Pneumonectomy has generally been performed for centrally located tumors but recently conservative resection for low grade tumors been performed without compromising oncologic outcome [5][6][7][8] avoiding pneumonectomy, whenever distal lung function is conserved and surgical planes of resection are adequate [9,10]. Wedge bronchoplasty, flap bronchoplasty, sleeve lobectomy and lung parenchyma preserving bronchotomy are the types of lung conservative surgery.…”

Section: Discussionmentioning

confidence: 99%

Bronchoscopic Debulking Followed by Bronchoplastic Procedure Helps in Limiting Lung Resection in a Bronchial Carcinoid: A Case Report

Pandey

Ramanathan

Khurse

et al. 2014

Indian J Surg Oncol

View full text Add to dashboard Cite

Bronchoplasty is a conservative procedure in lung surgeries used in the past for patients with poor functional status but recently these procedures have been performed in low grade malignant tumors of lung avoiding extensive morbid procedure like pneumonectomy without compromising the oncologic outcome. We describe a case of bronchial carcinoid treated by bronchoscopic intervention followed by wedge bronchoplasty. The importance of bronchoscopic debulking of the tumor for accurate assessment of its extent has been highlighted. A parenchyma preserving pulmonary resection can then be performed with bronchoplastic technique, thus avoiding pneumonectomy.

show abstract

Long-term survival after bronchial sleeve resection: Univariate and multivariate analyses

Cited by 63 publications

References 13 publications

Long-term outcome of hybrid surgical approach of video-assisted minithoracotomy sleeve lobectomy for non-small-cell lung cancer

Long-term outcome of hybrid surgical approach of video-assisted minithoracotomy sleeve lobectomy for non-small-cell lung cancer

Current surgical treatment of nonsmall cell lung cancer 2001

Bronchoscopic Debulking Followed by Bronchoplastic Procedure Helps in Limiting Lung Resection in a Bronchial Carcinoid: A Case Report

Contact Info

Product

Resources

About